| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.069 | 0.3 |